hotspot -WSS

hotspot

author：comprehensive 2025-09-30 00:35:58 - browse：525

Ed Silverman on the Breakthrough Summit stage in 2023. — STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

Below, you can find a lightly edited transcript of the conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Readout LOUD: Venture capital, Gilead, and more M&A

hotspot

WSS

Updated Covid vaccine has 54% effectiveness, new study suggests

Free medical tuition alone isn't enough to close gaps in primary care

What a koala virus tells us about the human genome

STAT reporters are Pulitzer Prize finalists for investigative reporting

Problems with a popular proposal to regulate AI in health care

Supreme Court to hear if Covid misinformation is protected speech

hotspot

hotspot

Wikipedia

Hollywood unions extend contract negotiations for actors

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Sports medicine is finally prioritizing gender equality

Texas Medical Board asked to define abortion emergency exception

Moonlake's readout produced a cash windfall. Risks remain

Bernie brings in new pharma CEOs to talk drug prices

Affirmative action in medical school literally saved lives

Devoted Health’s losses in Medicare Advantage persist

Drug repurposing or repositioning? The language matters

Cano Health’s bankruptcy is a warning for Medicare Advantage

entertainment

Why Novartis is going to walk from its acquisition of MorphoSys

Hottest summer in 2,000 years puts focus on extreme heat, health

AstraZeneca stays mum on Medicare drug pricing negotiations

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

A protest over insulin prices is seen as a fight for life

A single Democrat is willing to weaken Medicare negotiation power

hotspot

leisure time

hotspot

entertainment